WO2010114425A3 - Фармацевтическая композиция ингибитора протонной помпы и пребиотика для лечения язвенных поражений желудка и 12- перстной кишки - Google Patents

Фармацевтическая композиция ингибитора протонной помпы и пребиотика для лечения язвенных поражений желудка и 12- перстной кишки Download PDF

Info

Publication number
WO2010114425A3
WO2010114425A3 PCT/RU2010/000197 RU2010000197W WO2010114425A3 WO 2010114425 A3 WO2010114425 A3 WO 2010114425A3 RU 2010000197 W RU2010000197 W RU 2010000197W WO 2010114425 A3 WO2010114425 A3 WO 2010114425A3
Authority
WO
WIPO (PCT)
Prior art keywords
treatment
pharmaceutical composition
ulcer
prebiotic
proton pump
Prior art date
Application number
PCT/RU2010/000197
Other languages
English (en)
French (fr)
Other versions
WO2010114425A2 (ru
WO2010114425A8 (ru
Inventor
Александр Владимирович ДИКОВСКИЙ
Олег Валентинович ДОРОЖКО
Original Assignee
Dikovskiy Aleksander Vladimirovich
Dorozhko Oleg Valentinovich
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=42828898&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=WO2010114425(A3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority to SI201030845T priority Critical patent/SI2415475T1/sl
Priority to EP10759105.9A priority patent/EP2415475B1/en
Priority to ES10759105.9T priority patent/ES2527470T3/es
Priority to PL10759105T priority patent/PL2415475T3/pl
Priority to US13/257,361 priority patent/US20120028914A1/en
Priority to BRPI1014831A priority patent/BRPI1014831A2/pt
Priority to EA201100857A priority patent/EA022204B1/ru
Application filed by Dikovskiy Aleksander Vladimirovich, Dorozhko Oleg Valentinovich filed Critical Dikovskiy Aleksander Vladimirovich
Priority to DK10759105.9T priority patent/DK2415475T3/en
Priority to CN2010800074518A priority patent/CN102333534B/zh
Publication of WO2010114425A2 publication Critical patent/WO2010114425A2/ru
Publication of WO2010114425A3 publication Critical patent/WO2010114425A3/ru
Publication of WO2010114425A8 publication Critical patent/WO2010114425A8/ru
Priority to HRP20150001AT priority patent/HRP20150001T1/hr
Priority to US15/008,600 priority patent/US20160136194A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7032—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a polyol, i.e. compounds having two or more free or esterified hydroxy groups, including the hydroxy group involved in the glycosidic linkage, e.g. monoglucosyldiacylglycerides, lactobionic acid, gangliosides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7016—Disaccharides, e.g. lactose, lactulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/732—Pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/733—Fructosans, e.g. inulin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Для лечения язвенной болезни желудка и 12- перстной кишки предложена фармкомпозиция ингибиторов протонной помпы и пребиотиков, позволяющая проводить эффективную противоязвенную терапию и эрадикацию H. руlоri со слизистой желудка и 12-пepcтнoй кишки, без применения антибиотиков широкого спектра действия Комплексная терапия язвенной болезни, ассоциированной с хеликобактерной инфекцией, фармкомпозицией ИПП и пребиотика позволяет, в условиях повышения рН желудочного содержимого, активно стимулировать рост лактобацилл в верхних отделах ЖКТ, включая 12-пepcтнyю кишку, и существенно увеличить титры лактобацилл - антагонистов H. руlоri, что существенно повышает эффективность противоязвенной терапии. Высокая клиническая эффективность и безопасность, обусловленная синергизмом действия ингибитора протонной помпы и пребиотика в верхних отделах ЖКТ, отсутствие побочных эффектов и рецидивов, а также комплаентность комбинированной терапии заявленной фармкомпозиции, свидетельствуют о том, что предлагаемая рецептура является новым перспективным средством лечения язвенной болезни желудка и 12-пepcтнoй кишки. Использование заявленной композиции драматически снижает число рецидивов заболевания.
PCT/RU2010/000197 2009-03-30 2010-04-23 Фармацевтическая композиция ингибитора протонной помпы и пребиотика для лечения язвенных поражений желудка и 12- перстной кишки WO2010114425A2 (ru)

Priority Applications (11)

Application Number Priority Date Filing Date Title
CN2010800074518A CN102333534B (zh) 2009-03-30 2010-04-23 用于治疗胃溃疡和十二指肠溃疡的包括质子泵抑制剂及益生元的药物组合物
EA201100857A EA022204B1 (ru) 2009-03-30 2010-04-23 Фармацевтическая композиция ингибитора протонной помпы и пребиотика для лечения язвенной болезни желудка и 12-перстной кишки
ES10759105.9T ES2527470T3 (es) 2009-03-30 2010-04-23 Composición farmacéutica que comprende un inhibidor de la bomba de protones y un prebiótico para el tratamiento de lesiones ulcerosas del estómago y el duodeno
PL10759105T PL2415475T3 (pl) 2009-03-30 2010-04-23 Kompozycja farmaceutyczna zawierająca inhibitor pompy protonowej i prebiotyk do leczenia zmian wrzodowych żołądka i dwunastnicy
US13/257,361 US20120028914A1 (en) 2009-03-30 2010-04-23 Pharmaceutical composition comprising a proton pump inhibitor and a prebiotic for the treatment of ulcerous lesions of the stomach and duodenum
BRPI1014831A BRPI1014831A2 (pt) 2009-03-30 2010-04-23 composição farmacêutica compreendendo um inibidor de bomba de próton e um prebiótico para o tratamento de lesões ulcerosas do estômago e duodeno.
DK10759105.9T DK2415475T3 (en) 2009-03-30 2010-04-23 PHARMACEUTICAL COMPOSITION COMPRISING A PROTON PUMP INHIBITOR AND A prebiotic, FOR THE TREATMENT OF ulcerative lesions of the stomach and duodenum
SI201030845T SI2415475T1 (sl) 2009-03-30 2010-04-23 Farmacevtski pripravek, ki obsega inhibitor protonske ÄŤrpalke ter prebiotik za zdravljenje ulceroznih lezij Ĺľelodca in dvanajsternika
EP10759105.9A EP2415475B1 (en) 2009-03-30 2010-04-23 Pharmaceutical composition comprising a proton pump inhibitor and a prebiotic for the treatment of ulcerous lesions of the stomach and duodenum
HRP20150001AT HRP20150001T1 (hr) 2009-03-30 2015-01-01 Farmaceutski pripravak koji sadrži inhibitor protonske pumpe i prebiotik za lijeäśenje ulceroznih lezija želuca i dvanaesterca
US15/008,600 US20160136194A1 (en) 2009-03-30 2016-01-28 Pharmaceutical composition comprising a proton pump inhibitor and a prebiotic for the treatment of ulcerous lesions of the stomach and duodenum

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
RU2009111362/15A RU2410100C2 (ru) 2009-03-30 2009-03-30 Фармацевтическая композиция ингибитора протонной помпы и пребиотика для лечения язвенных поражений желудка и 12-перстной кишки
RU2009111362 2009-03-30

Related Child Applications (2)

Application Number Title Priority Date Filing Date
US13/257,361 A-371-Of-International US20120028914A1 (en) 2009-03-30 2010-04-23 Pharmaceutical composition comprising a proton pump inhibitor and a prebiotic for the treatment of ulcerous lesions of the stomach and duodenum
US15/008,600 Division US20160136194A1 (en) 2009-03-30 2016-01-28 Pharmaceutical composition comprising a proton pump inhibitor and a prebiotic for the treatment of ulcerous lesions of the stomach and duodenum

Publications (3)

Publication Number Publication Date
WO2010114425A2 WO2010114425A2 (ru) 2010-10-07
WO2010114425A3 true WO2010114425A3 (ru) 2011-01-06
WO2010114425A8 WO2010114425A8 (ru) 2011-12-08

Family

ID=42828898

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/RU2010/000197 WO2010114425A2 (ru) 2009-03-30 2010-04-23 Фармацевтическая композиция ингибитора протонной помпы и пребиотика для лечения язвенных поражений желудка и 12- перстной кишки

Country Status (15)

Country Link
US (2) US20120028914A1 (ru)
EP (1) EP2415475B1 (ru)
CN (1) CN102333534B (ru)
BR (1) BRPI1014831A2 (ru)
CY (1) CY1116050T1 (ru)
DK (1) DK2415475T3 (ru)
EA (1) EA022204B1 (ru)
ES (1) ES2527470T3 (ru)
HR (1) HRP20150001T1 (ru)
PL (1) PL2415475T3 (ru)
PT (1) PT2415475E (ru)
RU (1) RU2410100C2 (ru)
SI (1) SI2415475T1 (ru)
UA (1) UA97078C2 (ru)
WO (1) WO2010114425A2 (ru)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2449787C1 (ru) * 2011-01-12 2012-05-10 Государственное образовательное учреждение высшего профессионального образования "Пермская государственная медицинская академия имени академика Е.А. Вагнера Федерального агентства по здравоохранению и социальному развитию" Способ лечения эрозивных и язвенных поражений слизистой оболочки желудка
DE102011013524A1 (de) * 2011-03-10 2012-09-13 SC "PharmVILAR" CJSC Mittel EXPORTAL mit gastroprotektiver (antiulceröser) Wirkung
RU2501549C1 (ru) 2012-08-30 2013-12-20 Авва Девелопмент Лтд Фармацевтическая композиция для лечения гастроэзофагеальной рефлюксной болезни
CN108159059A (zh) * 2017-12-15 2018-06-15 哈尔滨珍宝制药有限公司 一种包含埃索美拉唑钠的药物组合物及其制备方法
CN108904546A (zh) * 2018-07-10 2018-11-30 山东腾贵医药有限公司 一种对幽门螺旋杆菌有抑制、杀灭作用的益生菌组合制剂及其制备方法
CN111166776A (zh) * 2018-11-10 2020-05-19 湖南益优健康产业有限公司 一种根除幽门螺杆菌引起的慢性胃炎的配方
CN109566951B (zh) * 2018-11-26 2021-09-17 大兴安岭北天原生物科技有限责任公司 含黄芪或黄芪茎、叶、花的护胃咀嚼片
CN109497557B (zh) * 2019-01-06 2022-07-15 赵勤农 一种抗Hp感染促进胃部菌群平衡的组合物及其应用
CN111903962A (zh) * 2020-05-25 2020-11-10 上海复旦奥医医学科技有限公司 一种胃溃疡和十二指肠溃疡专用型临床营养配方及其制备

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994003184A1 (en) * 1992-07-31 1994-02-17 Neose Pharmaceuticals, Inc. Compositions for treating and inhibiting gastric and duodenal ulcers
WO1998023272A1 (en) * 1996-11-27 1998-06-04 The Procter & Gamble Company Compositions and methods for the treatment of gastrointestinal disorders
RU2184558C2 (ru) * 2000-08-07 2002-07-10 Нижегородская государственная медицинская академия Способ лечения язвенной болезни двенадцатиперстной кишки
WO2007117175A1 (en) * 2006-04-10 2007-10-18 Avva Pharmaceuticals Ag Pharmaceutical composition of enterosorbent and prebiotics, dosage forms, and the method for prevention and treatment of gastrointestinal disorders
RU2325187C1 (ru) * 2006-11-21 2008-05-27 Александр Владимирович Диковский Фармацевтическая композиция антибиотиков и пребиотиков (варианты) для профилактики и лечения дисбиозов в процессе антибактериальной терапии

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX9304638A (es) * 1992-07-31 1994-05-31 Neose Pharm Inc Composicion para tratar e inhibir las ulceras gastricas y duodenales.
WO1994018986A1 (en) * 1993-02-26 1994-09-01 Jan Staffan Normark Use of oligosaccharide glycosides as inhibitors of bacterial adherence
US6117868A (en) 1998-09-16 2000-09-12 Ed. Geistlich Sohne Ag Fur Chemische Industrie Treatment of gastrointestinal ulcers or gastritis caused by microbial infection
FI20011403A (fi) * 2001-06-29 2002-12-30 Carbion Oy Menetelmä ja koostumukset vatsan sairauksien hoitoon
US6685427B1 (en) * 2002-07-23 2004-02-03 General Electric Company Brush seal for a rotary machine and method of retrofitting
US20050031696A1 (en) * 2003-04-22 2005-02-10 Dr. Reddy's Laboratories Limited Oral pharmaceutical formulations of acid-labile active ingredients and process for making same
US7670624B2 (en) * 2004-01-29 2010-03-02 Astella Pharma Inc. Gastrointestinal-specific multiple drug release system
CA2566771A1 (en) * 2004-06-07 2005-12-22 Wyeth Sugar coatings and methods therefor

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994003184A1 (en) * 1992-07-31 1994-02-17 Neose Pharmaceuticals, Inc. Compositions for treating and inhibiting gastric and duodenal ulcers
WO1998023272A1 (en) * 1996-11-27 1998-06-04 The Procter & Gamble Company Compositions and methods for the treatment of gastrointestinal disorders
RU2184558C2 (ru) * 2000-08-07 2002-07-10 Нижегородская государственная медицинская академия Способ лечения язвенной болезни двенадцатиперстной кишки
WO2007117175A1 (en) * 2006-04-10 2007-10-18 Avva Pharmaceuticals Ag Pharmaceutical composition of enterosorbent and prebiotics, dosage forms, and the method for prevention and treatment of gastrointestinal disorders
RU2325187C1 (ru) * 2006-11-21 2008-05-27 Александр Владимирович Диковский Фармацевтическая композиция антибиотиков и пребиотиков (варианты) для профилактики и лечения дисбиозов в процессе антибактериальной терапии

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of EP2415475A4 *

Also Published As

Publication number Publication date
US20120028914A1 (en) 2012-02-02
ES2527470T3 (es) 2015-01-26
EA022204B1 (ru) 2015-11-30
RU2410100C2 (ru) 2011-01-27
US20160136194A1 (en) 2016-05-19
HRP20150001T1 (hr) 2015-02-27
DK2415475T3 (en) 2015-01-12
WO2010114425A2 (ru) 2010-10-07
EP2415475A4 (en) 2012-09-05
EA201100857A1 (ru) 2011-12-30
CY1116050T1 (el) 2017-01-25
PL2415475T3 (pl) 2015-03-31
CN102333534A (zh) 2012-01-25
EP2415475B1 (en) 2014-12-31
PT2415475E (pt) 2015-01-13
EP2415475A2 (en) 2012-02-08
SI2415475T1 (sl) 2015-03-31
RU2009111362A (ru) 2010-10-10
WO2010114425A8 (ru) 2011-12-08
BRPI1014831A2 (pt) 2016-04-12
UA97078C2 (ru) 2011-12-26
CN102333534B (zh) 2013-01-02

Similar Documents

Publication Publication Date Title
WO2010114425A3 (ru) Фармацевтическая композиция ингибитора протонной помпы и пребиотика для лечения язвенных поражений желудка и 12- перстной кишки
WO2009017716A3 (en) Pulsatile gastric retentive dosage forms
WO2010081720A3 (en) Compositions for the treatment of gastro-esofageal reflux disease (gerd)
EP3434687A3 (en) Novel oxyntomodulin derivatives and pharmaceutical composition for treating obesity comprising the same
WO2009064460A3 (en) Gastrointestinal delivery systems
WO2012033792A3 (en) Treatment of diseases
EP1992361A4 (en) MEDICINE FOR THE TREATMENT OR PREVENTION OF DIGESTIVE WEAKNESSES
WO2011151722A3 (en) Methods and compositions for oral pharmaceutical therapy
HRP20211046T1 (hr) Upotreba derivata benzimidazola kod noćnog proboja kiseline
NZ597534A (en) Method for treating a patient in need of aspirin therapy
WO2011037411A3 (en) Composition comprising s-allyl-l-cysteine as active ingredient for preventing or treating gastrointestinal disorders
WO2011113507A3 (en) Use of nitrocarboxylic acids for the treatment, diagnosis and prophylaxis of aggressive healing patterns
ATE521358T1 (de) Vorbeugender und/oder therapeutischer wirkstoff zur behandlung einer funktionellen gastrointestinalen erkrankung
JP2008266291A5 (ru)
EP2076277A4 (en) A METHOD FOR TREATING OR PREVENTING DETERIORATION, DAMAGE OR TISSUE DAMAGE DUE TO ORAL MUCOSAL DISEASE OR DISORDER AND / OR REGULATING NF-KAPPAB FALL OR REMOVING NF-KAPPAB ASSISTED ACTIONS
IL200364A0 (en) Method of treating or preventing tissue deterioration, injury or damage due to disease of mucosa
WO2013164652A3 (en) Microspheres for treating helicobacter pylori infections
WO2011080501A3 (en) New pharmaceutical dosage form for the treatment of gastric acid-related disorders
RU2006132127A (ru) Применение нифуроксазида в качестве компонента комбинированной лекарственной терапии заболеваний, ассоциированных с helicobacter pylori, и способ лечения, направленный на эрадикацию возбудителя
RU2007129408A (ru) Способ выращивания поросят в период откорма
CN106552154A (zh) 一种治浅表性胃及十二指肠溃疡的配方
Hong optimizing Acid Reflux management: obstacles and opportunities
CN104906577B (zh) 一种根除幽门螺杆菌的药物组合物及其制备方法
WO2014141075A1 (es) Combinaciones con probióticos para restablecer alteraciones de la función intestinal
Huhlina et al. EXPERIENCE OF MELDONIUM IN COMBINED THERAPY OF STABLE ANGINA AND GASTROESOPHAGEAL REFLUX DISEASE

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 201080007451.8

Country of ref document: CN

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 10759105

Country of ref document: EP

Kind code of ref document: A2

WWE Wipo information: entry into national phase

Ref document number: 201100857

Country of ref document: EA

WWE Wipo information: entry into national phase

Ref document number: 2010759105

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: a201107579

Country of ref document: UA

Ref document number: 12011501606

Country of ref document: PH

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 7083/CHENP/2011

Country of ref document: IN

WWE Wipo information: entry into national phase

Ref document number: 13257361

Country of ref document: US

REG Reference to national code

Ref country code: BR

Ref legal event code: B01A

Ref document number: PI1014831

Country of ref document: BR

ENP Entry into the national phase

Ref document number: PI1014831

Country of ref document: BR

Kind code of ref document: A2

Effective date: 20110928